Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

CRT 2025 Insights: What Did We Learn From the ECLIPSE Trial of Orbit…

CRT 2025 Insights

G. Stone

CT FFR Is Already the Gold Standard for Ischemia Evaluation. Here Is…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

K. Al-Azizi

Cerebral Embolic Protection in TAVR

Northwell Fellows Course 2020

A. Tariq

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification:…

ESC 2024 Insights

A. Kini

Emotional Toll of Complications

The Christ Hospital Heart & Vascular Institute

W. Lombardi

A Simplified, Integrated, Physiology and Evidence Based Approach to …

The Texas Heart Institute

D. Brown

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Co-Registration: Do We Really Need It? - 2025 Update

ARCH Advanced Revascularization Symposium

P. Thakker

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Combined ROTA and IVL for Treating a Severe Left Main Calcified Lesi…

ARCH Advanced Revascularization Symposium

L. Wei

Complete Revascularization Before TAVR

NorthShore Advanced Cardiovascular Therapeutics

H. Salam

Q&A: Are We Underusing CABG?

Cedars Sinai

J. Chikwe

Calcium Modification Strategies - 2025 Update

ARCH Advanced Revascularization Symposium

P. D. Thakker